TransCode Therapeutics (RNAZ)
(Delayed Data from NSDQ)
$0.86 USD
-0.01 (-1.49%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $0.86 0.00 (0.35%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2024
Time: -- |
6/2024 | $-0.58 | 0.00% |
Earnings Summary
For their last quarter, TransCode Therapeutics (RNAZ) reported earnings of -$0.65 per share, beating the Zacks Consensus Estimate of $-0.70 per share. This reflects a positive earnings surprise of 7.14%. Look out for RNAZ's next earnings release expected on August 12, 2024. For the next earning release, we expect the company to report earnings of -$0.58 per share, reflecting a year-over-year increase of 99.56%.
Earnings History
Price & Consensus
Zacks News for RNAZ
TransCode (RNAZ) Down 50% on Issue of New Common Stock
RNAZ: What are Zacks experts saying now?
Zacks Private Portfolio Services